PROGNOSTIC AND PREDICTIVE RELEVANCE OF IMMUNOHISTOCHEMICALLY DETERMINED P53 MUTATION IN GLIOBLASTOMA

被引：0
|
作者：
Kempter, J. [1 ]
Gempt, J. [2 ]
Wiestler, B. [3 ]
Combs, S. E. [4 ]
Schlegel, J. [5 ]
Liesche-Starnecker, F. [1 ,5 ]
Schmidt-Graf, F.
机构：
[1] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany
[2] Tech Univ Munich, Sch Med, Dept Neurosurg, Munich, Germany
[3] Tech Univ, Sch Med, Dept Diagnost & Intervent Neuroradiol, Munich, Germany
[4] Tech Univ Munich, Sch Med, Dept Radiat Oncol, Munich, Germany
[5] Tech Univ Munich, Inst Pathol, Sch Med, Dept Neuropathol, Munich, Germany
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
10.1093/neuonc/noac174.211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11.22.A
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance
    Wurl, P
    Weigmann, F
    Meye, A
    Fittkau, M
    Rose, U
    Berger, D
    Rath, FW
    Dralle, H
    Taubert, H
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (11) : 1147 - 1151
  • [32] Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas
    Taubert, H
    Würl, P
    Meye, A
    Bache, M
    Kroll, J
    Lautenschläger, C
    Thamm, B
    Holzhausen, HJ
    Hinze, R
    Schmidt, H
    Berger, D
    Rath, FW
    PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 340 - 344
  • [33] P53, MDR1 and SPF prognostic relevance in breast cancer
    Vielh, P
    Pouillart, P
    Klijanienko, J
    Fourquet, A
    Chevillard, S
    LABORATORY INVESTIGATION, 1998, 78 (01) : 29A - 29A
  • [34] THE P53 FAMILY TARGET GENE SIGNATURE IS OF PROGNOSTIC RELEVANCE IN HEPATOCELLULAR CARCINOMA
    Staib, F.
    Mundt, H.
    Koch, A.
    Krupp, M.
    Galle, P. R.
    Stremmel, W.
    Teufel, A.
    Mueller, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S350 - S351
  • [35] Prognostic relevance of P53 expression in laryngeal squamous cell carcinoma (LSCC)
    Besma, L.
    Mhiri, M.
    El Hadj, O. El Amine
    Kammoun, C.
    Gargouri, F.
    Bouziani, A.
    Msakni, I.
    VIRCHOWS ARCHIV, 2017, 471 : S154 - S154
  • [36] p53, MDR1 and SPF prognostic relevance in breast cancer
    Vielh, P
    Pouillart, P
    Klijanienko, J
    Fourquet, A
    Chevillard, S
    MODERN PATHOLOGY, 1998, 11 (01) : 29A - 29A
  • [37] Prognostic significance of p53 immunohistochemistry for p53 mutated tumors
    Wurl, P
    Dralle, H
    Taubert, H
    Meye, A
    Berger, D
    Schmidt, H
    Holzhausen, HJ
    Rath, FW
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 333 - 333
  • [38] Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer
    Bae, Soo Youn
    Jung, Seung Pit
    Lee, Se Kyung
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2018, 34 (12): : 663 - 672
  • [39] Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
    Lenos, Kristiaan
    Grawenda, Anna M.
    Lodder, Kirsten
    Kuijjer, Marieke L.
    Teunisse, Amina F. A. S.
    Repapi, Emmanouela
    Grochola, Lukasz F.
    Bartel, Frank
    Hogendoorn, Pancras C. W.
    Wuerl, Peter
    Taubert, Helge
    Cleton-Jansen, Anne-Marie
    Bond, Gareth L.
    Jochemsen, Aart G.
    CANCER RESEARCH, 2012, 72 (16) : 4074 - 4084
  • [40] Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: A Gynecologic Oncology Group Study
    Havrilesky, L
    Darcy, KM
    Hamdan, H
    Priore, RL
    Leon, J
    Bell, J
    Berchuck, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) : 3814 - 3825
12345